ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

Carvalho D., Taylor KR., Olaciregui NG., Molinari V., Clarke M., Mackay A., Ruddle R., Henley A., Valenti M., Hayes A., Brandon ADH., Eccles SA., Raynaud F., Boudhar A., Monje M., Popov S., Moore AS., Mora J., Cruz O., Vinci M., Brennan PE., Bullock AN., Carcaboso AM., Jones C.

DOI

10.1038/s42003-019-0420-8

Type

Journal article

Journal

Communications Biology

Publisher

Springer Science and Business Media LLC

Publication Date

12/2019

Volume

2

Permalink Original publication